|

Fluorescence-Guided Optimization of Sarcoma Margins

RECRUITINGN/ASponsored by University of Aarhus
Actively Recruiting
PhaseN/A
SponsorUniversity of Aarhus
Started2025-09-01
Est. completion2028-02-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07134192

Summary

This is a Danish national multicenter prospective cohort study to evaluate if fluorescence-guided surgery (FGS) using indocyanine green (ICG) can reduce the rate of positive margins following sarcoma resection.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Biopsy verified intermediate-to-high grade sarcoma of theextremity or trunk wall
* Age\>18 years old
* Tumor operable
* Curative intent at time of surgery
* Consent of patient

Exclusion Criteria:

* History of allergic reaction to iodine-containing pharmaceuticals
* End-stage renal disease or eGFR \<15
* Patient decision
* Lack of capacity
* Inoperability

Conditions3

CancerSarcomaSoft Tissue Sarcoma of the Trunk and Extremities

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.